EYPT
EyePoint Pharmaceuticals Inc
Price:  
10.42 
USD
Volume:  
725,458.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EYPT EV/EBITDA

-340.3%
Upside

As of 2025-07-19, the EV/EBITDA ratio of EyePoint Pharmaceuticals Inc (EYPT) is -3.96. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EYPT's latest enterprise value is 631.84 mil USD. EYPT's TTM EBITDA according to its financial statements is -159.64 mil USD. Dividing these 2 quantities gives us the above EYPT EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.2x - 10.2x 8.0x
Forward P/E multiples 11.1x - 17.0x 14.6x
Fair Price (24.61) - (22.43) (25.04)
Upside -336.1% - -315.2% -340.3%
10.42 USD
Stock Price
(25.04) USD
Fair Price

EYPT EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-17 -3.91
2025-07-16 -3.80
2025-07-15 -3.71
2025-07-14 -3.85
2025-07-11 -3.93
2025-07-10 -4.23
2025-07-09 -4.19
2025-07-08 -3.76
2025-07-07 -3.56
2025-07-03 -3.66
2025-07-02 -3.63
2025-07-01 -3.58
2025-06-30 -3.52
2025-06-27 -3.62
2025-06-26 -3.94
2025-06-25 -4.01
2025-06-24 -3.42
2025-06-23 -3.04
2025-06-20 -3.10
2025-06-18 -3.31
2025-06-17 -3.26
2025-06-16 -3.30
2025-06-13 -3.36
2025-06-12 -3.29
2025-06-11 -3.26
2025-06-10 -3.44
2025-06-09 -3.32
2025-06-06 -3.32
2025-06-05 -3.02
2025-06-04 -3.00
2025-06-03 -2.97
2025-06-02 -2.66
2025-05-30 -2.59
2025-05-29 -2.57
2025-05-28 -2.50
2025-05-27 -2.04
2025-05-23 -1.91
2025-05-22 -1.88
2025-05-21 -2.00
2025-05-20 -2.14
2025-05-19 -2.10
2025-05-16 -2.11
2025-05-15 -1.93
2025-05-14 -1.83
2025-05-13 -2.01
2025-05-12 -1.99
2025-05-09 -1.97
2025-05-08 -2.10
2025-05-07 -2.09
2025-05-06 -2.16